From disparity to difference: how race-specific medicines may undermine policies to address inequalities in health care.
Kahn
Jonathan
J
Hamline University School of Law, USA.
D001741:Black or African American / Q000235:genetics; D004338:Drug Combinations; D005006:Ethnicity / Q000235:genetics; D006291:Health Policy; D006297:Health Services Accessibility; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006830:Hydralazine; D007548:Isosorbide Dinitrate; D010597:Pharmacogenetics; D011287:Prejudice; D012935:Social Justice; D012959:Socioeconomic Factors; D014481:United States
D004338:Drug Combinations; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D007548:Isosorbide Dinitrate